Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Chinese Yuan: Gradual gains toward 6.6640 against US Dollar – UOB

Chinese Yuan: Gradual gains toward 6.6640 against US Dollar – UOB

FXStreetFXStreet2026/10/22 20:00

United Overseas Bank (UOB) strategists Quek Ser Leang and Lee Sue Ann note USD/CNH is drifting lower, with intraday risks skewed toward a brief dip below 6.6700, though they do not expect a sustained break. Over the next one to three weeks they see scope for a gradual move toward 6.6640 as long as the pair stays below strong resistance at 6.6850. Their 1–3 month view keeps a broader downside bias while USD/CNH trades below the cloud near 6.7815.

Offshore Yuan retains mild strengthening bias

"24-HOUR VIEW: We indicated yesterday that USD “could dip below 6.6720 and test 6.6700.” However, we pointed out that “a continued decline below 6.6700 is unlikely.” We noted that “resistance is at 6.6805.” Our view did not materialise, as USD rose to 6.6795, and then dropped back down to close largely unchanged at 6.6750 (+0.01%). The slight increase in downward momentum suggests USD could dip below 6.6700 today. Based on the prevailing momentum, a sustained decline below this level is unlikely. On the upside, resistance is at 6.6780."

"1-3 WEEKS VIEW: Our update from yesterday (21 Oct, spot at 6.6750) still stands. As highlighted, “as long as USD holds below 6.6850 (‘strong resistance’ level), it could decline gradually toward 6.6640.” A breach of the ‘strong resistance’ would indicate that the downward pressure from early last week has faded."

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Gilead Sciences (GILD.US) acquires PepStar’s oral inflammation drug program for $1.275 billion in cash, increasing investment in inflammatory bowel disease pipeline

Gilead Sciences will acquire PepStar’s anti-inflammatory drug program for $1.28 billions.

智通财经•2026/10/23 00:37

Japan's core CPI rose 2.1% year-on-year in September, surpassing the central bank's 2% target for the first time in nine months! Broadening inflation strengthens expectations of a near-term rate hike.

Data released on Friday showed that Japan’s core Consumer Price Index (CPI) rose by 2.1% year-on-year in September, exceeding the Bank of Japan’s 2% inflation target for the first time in nine months. This indicates that price pressures are spreading and reinforces market expectations of an interest rate hike in the near future.

智通财经•2026/10/23 00:26
Japan's core CPI rose 2.1% year-on-year in September, surpassing the central bank's 2% target for the first time in nine months! Broadening inflation strengthens expectations of a near-term rate hike.

DoubleLine Capital: Large-Scale Borrowing and Weak Demand Will Continue to Put Pressure, Still Bearish on Long-Term U.S. Treasuries

DoubleLine Capital Deputy Chief Investment Officer Jeffrey Sherman stated that he remains bearish on long-term U.S. Treasury bonds, believing that large-scale government borrowing and weak demand will continue to put pressure on the U.S. Treasury market.

智通财经•2026/10/22 23:57
DoubleLine Capital: Large-Scale Borrowing and Weak Demand Will Continue to Put Pressure, Still Bearish on Long-Term U.S. Treasuries